Reuters logo
BRIEF-Ganaxolone IV clinical data presented at leading international status Epilepticus Medical Conference
2017年4月10日 / 中午11点41分 / 7 个月前

BRIEF-Ganaxolone IV clinical data presented at leading international status Epilepticus Medical Conference

April 10 (Reuters) - Marinus Pharmaceuticals Inc

* Ganaxolone IV clinical data presented at leading international status Epilepticus Medical Conference

* Marinus Pharma - Results showed every dose regimen of Ganaxolone IV given was generally safe,well-tolerated, reached targeted dose levels in shortperiod of time Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below